Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 4;12(3):365.
doi: 10.3390/genes12030365.

Ophthalmologic Manifestations of Primary Sjögren's Syndrome

Affiliations
Review

Ophthalmologic Manifestations of Primary Sjögren's Syndrome

Anna Maria Roszkowska et al. Genes (Basel). .

Abstract

Sjögren's syndrome (SS) is a chronic, progressive, inflammatory, autoimmune disease, characterized by the lymphocyte infiltration of exocrine glands, especially the lacrimal and salivary, with their consequent destruction. The onset of primary SS (pSS) may remain misunderstood for several years. It usually presents with different types of severity, e.g., dry eye and dry mouth symptoms, due to early involvement of the lacrimal and salivary glands, which may be associated with parotid enlargement and dry eye; keratoconjunctivitis sicca (KCS) is its most common ocular manifestation. It is still doubtful if the extent ocular surface manifestations are secondary to lacrimal or meibomian gland involvement or to the targeting of corneal and conjunctival autoantigens. SS is the most representative cause of aqueous deficient dry eye, and the primary role of the inflammatory process was evidenced. Recent scientific progress in understanding the numerous factors involved in the pathogenesis of pSS was registered, but the exact mechanisms involved still need to be clarified. The unquestionable role of both the innate and adaptive immune system, participating actively in the induction and evolution of the disease, was recognized. The ocular surface inflammation is a central mechanism in pSS leading to the decrease of lacrimal secretion and keratoconjunctival alterations. However, there are controversies about whether the ocular surface involvement is a direct autoimmune target or secondary to the inflammatory process in the lacrimal gland. In this review, we aimed to present actual knowledge relative to the pathogenesis of the pSS, considering the role of innate immunity, adaptive immunity, and genetics.

Keywords: Primary ocular Sjögren’s syndrome; adaptive immunity; innate immunity; pathogenesis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Mathews P.M., Robinson S.A., Gire A., Baer A.N., Akpek E.K. Extraglandular ocular involvement and morbidity and mortality in primary Sjögren’s syndrome. PLoS ONE. 2020;15:e0239769. doi: 10.1371/journal.pone.0239769. - DOI - PMC - PubMed
    1. Tashbayev B., Rusthen S., Young A., Herlofson B.B., Hove L.H., Singh P.B., Rykke M., Aqrawi L.A., Chen X., Utheim Ø.A. Interdisciplinary, comprehensive oral and ocular evaluation of patients with primary Sjögren’s syndrome. Sci. Rep. 2017;7:10761. doi: 10.1038/s41598-017-10809-w. - DOI - PMC - PubMed
    1. Franceschini F., Cavazzana I., Andreoli L., Tincani A. The 2016 classification criteria for primary Sjogren’s syndrome: What’s new? BMC Med. 2017;15:69. doi: 10.1186/s12916-017-0837-1. - DOI - PMC - PubMed
    1. Hayashi T. Dysfunction of lacrimal and salivary glands in Sjögren’s syndrome: Nonimmunologic injury in preinflammatory phase and mouse model. J. Biomed. Biotechnol. 2011;2011:407031. doi: 10.1155/2011/407031. - DOI - PMC - PubMed
    1. Both T., Dalm V.A., van Hagen P.M., van Daele P.L. Reviewing primary Sjögren’s syndrome: Beyond the dryness—From pathophysiology to diagnosis and treatment. Int. J. Med. Sci. 2017;14:191–200. doi: 10.7150/ijms.17718. - DOI - PMC - PubMed